Cytokine dynamics and quality of life: unraveling the impact of cell-free and concentrated ascites reinfusion therapy in ovarian cancer patients. Ito R, Kagabu M, Sato S, Takatori E, Kaido Y, Nagasawa T, Shoji T, Hirayama T, Terao Y, Baba T. Int J Clin Oncol. 2025 Jan 4. doi: 10.1007/s10147-024-02682-1.
PMID: 39755760
庄子教授 TGCU研究
Comparison of Treatment Outcomes Between First-Line Chemotherapy With or Without Bevacizumab for Advanced Ovarian Clear Cell Carcinoma (Tohoku Gynecologic Cancer Unit: TGCU-RS001A Study). Shoji T, Takatori E, Nagasawa T, Kagabu M, Baba T, Shigeto T, Matsumura Y, Shimizu D, Terada Y, Seino M, Ohta T, Nagase S, Shigeta S, Tokunaga H, Shimada M, Kaiho-Sakuma M, Furukawa S, Soeda S, Watanabe T, Takahashi F, Yokoyama Y. Cancers (Basel). 2024 Nov 12;16(22):3801. doi: 10.3390/cancers16223801.